caspase 9 inhibitor iii is a synthetic peptide analog incorporating a reactive moiety designed to engage catalytic cysteine sites. The sequence allows investigation of substrate-recognition motifs and protease specificity. Researchers employ it to probe apoptotic signaling pathways and enzyme kinetics. Its tailored structure supports mechanistic studies of caspase activity.
CAT No: HB00092
CAS No:403848-57-7
Synonyms/Alias:403848-57-7;Ac-Leu-Glu-His-Asp-chloromethylketone;Caspase-9 Inhibitor III(Ac-LEHD-CMK);caspase 9 inhibitor iii;FA111088;PD088788;Caspase-9 Inhibitor III(Ac-LEHD-CMK)?;Ac-DL-Leu-DL-Glu-DL-His-DL-Asp-CH2Cl;G85499;4-[(2-acetamido-4-methylpentanoyl)amino]-5-[[1-[(1-carboxy-4-chloro-3-oxobutan-2-yl)amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More